Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 5

Results For "Good-Manufacturing-Practices"

75 News Found

Briefs: Granules India
Drug Approval | August 28, 2023

Briefs: Granules India

Granules India received approval from Brazilian Health Regulatory Agency ANVISA


Briefs: Concord Biotech, Cian Healthcare and Eris Lifesciences
News | August 23, 2023

Briefs: Concord Biotech, Cian Healthcare and Eris Lifesciences

Eris Lifesciences enters into term loan agreement with Citi Bank


Need to strengthen food safety scientific standards: NITI Aayog
Policy | July 24, 2023

Need to strengthen food safety scientific standards: NITI Aayog

There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits


Lonza launches new cell culture media system TheraPRO
News | July 18, 2023

Lonza launches new cell culture media system TheraPRO

The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production


Bliss GVS Pharma updates on inspection by USFDA
Drug Approval | June 16, 2023

Bliss GVS Pharma updates on inspection by USFDA

The company has now received the Establishment Inspection Report (EIR) indicating closure of the inspection


Venus Remedies receives Ukrainian GMP approval for Its Carbapenem, Oncology parenteral facilities
News | June 08, 2023

Venus Remedies receives Ukrainian GMP approval for Its Carbapenem, Oncology parenteral facilities

The company expects this approval in Baddi to pave the way for GMP certifications from European Medicines Agency and other PIC/S member nations


Venus Remedies gets Kenyan GMP certification for its manufacturing facilities in Baddi
Drug Approval | May 24, 2023

Venus Remedies gets Kenyan GMP certification for its manufacturing facilities in Baddi

The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans


Croda signs supply deals with Amyris, BSI for vaccine adjuvants
News | May 21, 2023

Croda signs supply deals with Amyris, BSI for vaccine adjuvants

These announcements are in line with Croda Pharma’s strategy to “Empower Biologics Delivery” and follows news on investments, earlier this year, to expand Croda Pharma’s global manufacturing capabilities to enable the next generation vaccines and therapeutic drugs.


Thermo Fisher Scientific expands its capabilities in France
News | April 10, 2023

Thermo Fisher Scientific expands its capabilities in France

Bourgoin early development hub broadens offerings for oral solid dose formulations


Jubilant Pharmova receives VAI from USFDA for its API manufacturing facility
Drug Approval | March 09, 2023

Jubilant Pharmova receives VAI from USFDA for its API manufacturing facility

Based on this inspection and the USFDA VAI classification, this facility is in compliance with regard to current good manufacturing practices (cGMP)